NeuroPace, Inc.
US ˙ NasdaqGM ˙ US6412881053

SecurityNPCE / NeuroPace, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership932,090 shares
Latest Disclosed Value $ 12,256,984
Deutsche Bank Ag\ reports 0.28% increase in ownership of NPCE / NeuroPace, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 932,090 shares of NeuroPace, Inc. (US:NPCE) valued at $12,256,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 929,522 shares of NeuroPace, Inc.. This represents a change in shares of 0.28% during the quarter. The current value of the position is $14,671,097 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F NEUROPACE COM 641288105 932,090 2,568 0.28 12,257 -14.60 0.0008
2026-02-11 2025-12-31 13F NEUROPACE COM 641288105 929,522 756 0.08 14,352 49.88 0.0047
2025-11-13 2025-09-30 13F NEUROPACE COM 641288105 928,766 0 0.00 9,576 -7.45 0.0032
2025-08-12 2025-06-30 13F NEUROPACE COM 641288105 928,766 4,492 0.49 10,346 -8.92 0.0038
2025-05-09 2025-03-31 13F NEUROPACE COM 641288105 924,274 511,662 124.01 11,359 146.03 0.0045
2025-06-30 2024-12-31 13F/A-1 NEUROPACE COM 641288105 412,612 356 0.09 4,617 60.70 0.0018
2025-02-14 2024-12-31 13F NEUROPACE COM 641288105 412,612 356 4,617 0.0018
2025-06-26 2024-09-30 13F/A-1 NEUROPACE COM 641288105 412,256 -241,429 -36.93 2,873 -41.85 0.0012
2024-11-13 2024-09-30 13F NEUROPACE COM 641288105 412,256 -241,429 2,873 0.0012
2025-06-12 2024-06-30 13F/A-1 NEUROPACE COM 641288105 653,685 653,685 4,942 0.0022
2024-08-14 2024-06-30 13F NEUROPACE COM 641288105 653,685 653,685 4,942 0.0022
2022-08-11 2022-06-30 13F NEUROPACE COM 641288105 0 -3,857 -100.00 0 -100.00
2022-05-13 2022-03-31 13F NEUROPACE COM 641288105 3,857 -460 -10.66 32 -27.27 0.0000
2022-02-16 2021-12-31 13F/A-1 NEUROPACE COM 641288105 4,317 230 5.63 44 -32.31 0.0000
2022-02-11 2021-12-31 13F NEUROPACE COM 641288105 4,317 230 44 0.0000
2021-11-04 2021-09-30 13F NEUROPACE COM 641288105 4,087 -46 -1.11 65 -33.67 0.0000
2021-08-11 2021-06-30 13F NEUROPACE COM 641288105 4,133 4,133 98 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.